Home › NDC Lookup › RxCUI directory › RxCUI 310014

Dornase alfa 1 MG/ML Inhalation Solution — RxCUI 310014

RxNorm drug concept · Semantic clinical drug
RxCUI 310014 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310014
Official nameDornase alfa 1 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)42,474 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dornase Alfa: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pulmozyme helps thin out the thick, sticky mucus that builds up in the airways because of CF. In CF, when your body's white blood cells fight infection and then break down, they re...
  • What exactly does Pulmozyme do for cystic fibrosis?
  • You breathe it in — not swallow it. Pulmozyme is inhaled through a nebulizer, which turns the liquid into a fine mist you breathe directly into your lungs through a mouthpiece or f...
  • How do I use Pulmozyme — do I swallow it or breathe it in?
📖 Read our full Dornase Alfa guide →

🕸️ Concept Web — How Dornase alfa 1 MG/ML Inhalation Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dornase alfa 1 MG/ML Inhalation Solution RxCUI 310014

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dornase alfa 337623
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pulmozyme 74704
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dornase alfa Inhalation Solution 2108354
    • Dornase alfa Inhalant Product 1160758
    • Dornase alfa Inhalation Solution [Pulmozyme] 2108356
    • Pulmozyme Inhalant Product 1183562
    • Inhalation Solution 346161
    • Inhalant Product 1151123
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dornase alfa 1 MG/ML SCDC · 345812
  • Dornase alfa Inhalation Solution SCDF · 2108354
  • Dornase alfa Inhalant Product SCDG · 1160758

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 310014 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0100-40 5 POUCH in 1 CARTON (50242-100-40) / 6 AMPULE in 1 POUCH (5... Pulmozyme Genentech, Inc. 1993-12-30
Observed labelers: Genentech, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$53.1220
Range $53.1220–$53.1220 · middle 50% $53.1220–$53.1220 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7639 Dornase alfa non-comp unit 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.